Genmab Stock (NASDAQ: GMAB) stock price, news, charts, stock research, profile.
Open | $27.70 |
Close | $27.94 |
Volume / Avg. | 900.70K / 561.94K |
Day Range | 27.62 - 28.08 |
52 Wk Range | 24.53 - 42.72 |
Market Cap | $17.13B |
P/E Ratio | 22.92 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 0.35% |
Days to Cover | 3.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Genmab (NASDAQ:GMAB) through any online brokerage.
Other companies in Genmab’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
There is no analysis for Genmab.
Genmab has a consensus price target of $42.13.
The stock price for Genmab (NASDAQ: GMAB) is $26.9908 last updated July 23, 2024 at 7:10 PM EDT.
There are no upcoming dividends for Genmab.
Genmab’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Genmab.
Genmab is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.